PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution


Autoria(s): Mainardes, R. M.; Evangelista, R. C.
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

20/05/2014

20/05/2014

16/02/2005

Resumo

Praziquantel has been shown to be highly effective against all known species of Schistosoma infecting humans. Spherical nanoparticulate drug carriers made of poly(D,L-lactide-co-glycolide) acid with controlled size were designed. Praziquantel, a hydrophobic molecule, was entrapped into the nanoparticles with theoretical loading varying from 10 to 30% (w/w). This investigates the effects of some process variables on the size distribution of nanoparticles prepared by emulsion-solvent evaporation method. The results show that sonication time, PLGA and drug amounts, PVA concentration, ratio between aqueous and organic phases, and the method of solvent evaporation have a significant influence on size distribution of the nanoparticles. (C) 2004 Elsevier B.V. All rights reserved.

Formato

137-144

Identificador

http://dx.doi.org/10.1016/j.ijpharm.2004.11.027

International Journal of Pharmaceutics. Amsterdam: Elsevier B.V., v. 290, n. 1-2, p. 137-144, 2005.

0378-5173

http://hdl.handle.net/11449/7591

10.1016/j.ijpharm.2004.11.027

WOS:000226985500015

Idioma(s)

eng

Publicador

Elsevier B.V.

Relação

International Journal of Pharmaceutics

Direitos

closedAccess

Palavras-Chave #nanoparticles #controlled release #PLGA #praziquantel #emulsification evaporation method
Tipo

info:eu-repo/semantics/article